Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038187 (
starvation
)
24,951
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
beta-D-Xylosides have been used to perturb proteoglycan (PG) synthesis to elucidate the function of PGs in a number of cellular processes, including proliferation, migration, and differentiation. This study was designed to examine whether specific xylosides affect the proliferation of several different cell types and, if so, whether this effect is dependent on altered PG synthesis via the false acceptor pathway. Both methylumbelliferyl beta-D-xylopyranoside and p-nitrophenyl beta-D-xylopyranoside (
PNP
beta-xyloside) inhibit cell proliferation and modulate PG synthesis; however, the alpha form of
PNP
xyloside which does not perturb PG synthesis inhibits the proliferation of cultured cells on a molar basis equally as well as the beta form. Conversely, beta-methyl xylopyranoside stimulates the synthesis of free glycosaminoglycan chains equally as well as
PNP
beta-xyloside and yet has no measurable effect on cell proliferation at comparable doses, indicating that cells can grow normally while experiencing disruption of their proteoglycan metabolism. At doses ranging from 0.5 to 5 mM,
PNP
beta-xyloside arrests cells in the G1 phase of the cell cycle at the same time point as serum
starvation
. It also delays the exist of cycling cells from the S phase. This treatment is not cytotoxic and is rapidly reversed by the replacement of
PNP
beta-xyloside containing medium with control medium. Dimethyl sulfoxide, the most commonly used solvent for beta-xyloside in proteoglycan studies, potentiates the inhibitory effect of
PNP
beta-xyloside on cell proliferation. These results indicate that the perturbation of PG synthesis via the false acceptor pathway can be uncoupled from control of cell proliferation.
...
PMID:Altered proteoglycan synthesis via the false acceptor pathway can be dissociated from beta-D-xyloside inhibition of proliferation. 163 72
Recent studies have demonstrated the existence of a physical complex containing p21ras (RAS), p74raf-1 (RAF-1), and MEK-1. Although it is clear that formation of this complex depends on the activation state of RAS, it is not known whether this complex is regulated by the activation state of the cell and whether MEK-2 is also present in the complex. To analyze the regulation and specificity of this complex, we utilized immobilized RAS to probe lysates of cultured NIH 3T3 fibroblasts and analyzed the proteins complexing with RAS following serum
starvation
or stimulation. Complex formation among RAS, RAF-1, and MEK-1 was dependent only on RAS:GMP-
PNP
and not on cell stimulation. Incubations of lysates with immobilized RAS depleted all RAF-1 from the lysate but bound only a small fraction of cytosolic MEK-1, and further MEK-1 could bind immobilized RAS only if exogenous RAF-1 was added to the lysate. This indicates that binding of MEK-1 to RAS depends on the presence of RAF-1 or an equivalent protein. In contrast to MEK-1, MEK-2 was not detected in the RAS signalling complex. A proline-rich region of MEK-1 containing a phosphorylation site appears to be essential for signalling complex formation. Consistent with the preferential binding of MEK-1 to RAS:RAF-1, the basal activity of MEK-1 in v-ras-transformed cells was found to be elevated sixfold, whereas MEK-2 was elevated only twofold, suggesting that the RAS signalling pathway favors MEK-1 activation.
...
PMID:RAS and RAF-1 form a signalling complex with MEK-1 but not MEK-2. 796 58
The genetic deficiency of human
PNP
causes a specific immunodeficiency by inducing apoptosis in dividing T-cells. Powerful inhibitors of
PNP
have been designed from the experimental determination of the transition state structure of PNPs. The Immucillins are transition state analogue inhibitors with Kd values as low as 7 pM. In the presence of deoxyguanosine the Immucillins kill activated human T-cells but not other cell types. The Immucillins are orally available and of low toxicity to mice. Immucillins also inhibit
PNP
from Plasmodium falciparum. Parasites cultured in human erythrocytes are killed by purine
starvation
in the presence of Immucillins and can be rescued by hypoxanthine.
...
PMID:Immucillins as antibiotics for T-cell proliferation and malaria. 1557 Dec 50
Nostoc muscorum and Spirulina platensis were grown under phosphate deficiency in order to investigate the role of internal phosphate pool and activity of alkaline phosphatase on poly-beta-hydroxybutyrate (PHB) accumulation. PHB accumulation in N. muscorum increased to 22.7% of dry weight (dw) after 4 day of phosphate deficiency, while the internal phosphate pool reduced to the level of 0.02 microM mg dw(-1) at a maximum APase activity of 2.57nM
PNP
mg dw(-1) h(-1). In contrary, S. platensis depicted maxima of 1.39nM
PNP
mg dw(-1) h(-1) on day 30 of incubation, which was about 2 fold lower than the observed value of N. muscorum. PHB content in S. platensis remained low even after prolonged phosphate
starvation
, and a rise only up to 3.5% of dw was recorded on day 60 of phosphate deficiency. Supplementation of NADPH exogenously to S. platensis cultures grown under phosphate deficiency favoured PHB accumulation in 10, 20 and 30 days old cultures, but not in the cultures grown under phosphate deficiency for 60 days. The possible role of phosphate limitation on PHB accumulation is discussed.
...
PMID:Poly-beta-hydroxybutyrate accumulation in Nostoc muscorum and Spirulina platensis under phosphate limitation. 1642 56
The study regards para-nitrophenol (p-NP) removal by a mixed culture in a batch reactor under aerobic conditions performed at low ratio substrate (p-NP) to p-NP degrading microorganisms (0.09 < I(0)/(X(B,
PNP
))(0) < 0.80 g COD(
PNP
)g VSS(-1)). p-NP biodegradation was modelled with a dual-biomass kinetic including Haldane formalism. The purpose was to examine the effect of operating conditions of acclimation phases in the kinetic parameters estimated by respirometric measurements. The experiments were conducted with a series of successive additions of p-NP and a biogenic substrate (Ss) in different proportions (0 < R = Ss/I < 6.6). To place emphasis on decisive role played by frequency and amount of p-NP supply, a parallel was drawn with continuous processes, characterising acclimation cycles by different organic loading rate (207 < OLR < 1490 mg COD(
PNP
) l(-1) d(-1)). During acclimation, results showed progressively decreasing half saturation constant (K(s)(
PNP
)) values (11.4-1.21 mg CODl(-1)) whereas inhibition coefficient K(I)(
PNP
) increased (72.4-289 mg CODl(-1)), as the specific degradation rate increased. The inverse behaviour was observed during
starvation
periods. At the end of acclimation, higher values of growth yield (0.39 < Y(
PNP
) < 0.63 mg COD(X) mg COD(
PNP
)(-1)) and maximum growth rate (1.09 < mu(max)(
PNP
) < 2.01 d(-1)) were obtained for cycles with low R.
...
PMID:Variability of kinetic parameters due to biomass acclimation: case of para-nitrophenol biodegradation. 1953 63
Plasmodium falciparum
causes the most lethal form of human malaria and is a global health concern. The parasite responds to antimalarial therapies by developing drug resistance. The continuous development of new antimalarials with novel mechanisms of action is a priority for drug combination therapies. The use of transition-state analog inhibitors to block essential steps in purine salvage has been proposed as a new antimalarial approach. Mutations that reduce transition-state analog binding are also expected to reduce the essential catalytic function of the target. We have previously reported that inhibition of host and
P. falciparum
purine nucleoside phosphorylase (
Pf
PNP
) by DADMe-Immucillin-G (DADMe-ImmG) causes purine
starvation
and parasite death in vitro and in primate infection models.
P. falciparum
cultured under incremental DADMe-ImmG drug pressure initially exhibited increased
Pf
PNP
gene copy number and protein expression. At increased drug pressure, additional
Pf
PNP
gene copies appeared with point mutations at catalytic site residues involved in drug binding. Mutant
Pf
PNPs from resistant clones demonstrated reduced affinity for DADMe-ImmG, but also reduced catalytic efficiency. The catalytic defects were partially overcome by gene amplification in the region expressing
Pf
PNP
. Crystal structures of native and mutated
Pf
PNPs demonstrate altered catalytic site contacts to DADMe-ImmG. Both point mutations and gene amplification are required to overcome purine
starvation
induced by DADMe-ImmG. Resistance developed slowly, over 136 generations (2
136
clonal selection). Transition-state analog inhibitors against
Pf
PNP
are slow to induce resistance and may have promise in malaria therapy.
...
PMID:Genetic resistance to purine nucleoside phosphorylase inhibition in
Plasmodium falciparum
. 2944 Apr 12